This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1990:79:72-3.

doi: 10.1159/000418153.

Renal function studies using 99mTc-MAG3: pharmacokinetics and slope clearance determination

B Bubeck¹, W Brandau, E Weber, S Pomer, P Georgi, K zum Winkel

Affiliations

PMID: 2146089
DOI: 10.1159/000418153

Renal function studies using 99mTc-MAG3: pharmacokinetics and slope clearance determination

B Bubeck et al. Contrib Nephrol. 1990.

. 1990:79:72-3.

doi: 10.1159/000418153.

Authors

B Bubeck¹, W Brandau, E Weber, S Pomer, P Georgi, K zum Winkel

Affiliation

¹ Department of Nuclear Medicine, University of Heidelberg, FRG.

PMID: 2146089
DOI: 10.1159/000418153

No abstract available

PubMed Disclaimer

Similar articles

Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance.
Taylor A Jr, Corrigan P, Eshima D, Folks R. Taylor A Jr, et al. J Nucl Med. 1992 Sep;33(9):1620-2. J Nucl Med. 1992. PMID: 1387682
Pharmacokinetics of technetium-99m-MAG3 in humans.
Bubeck B, Brandau W, Weber E, Kälble T, Parekh N, Georgi P. Bubeck B, et al. J Nucl Med. 1990 Aug;31(8):1285-93. J Nucl Med. 1990. PMID: 2143528
Preliminary results comparing OIH, 99mTc-MAG3 and iothalamate in a rat model of renal ischemia.
Eshima D, Greene J, Taylor A Jr. Eshima D, et al. Contrib Nephrol. 1990;79:24-7. doi: 10.1159/000418143. Contrib Nephrol. 1990. PMID: 2146085 No abstract available.
Radionuclide renal studies.
Abdel-Dayem HM, Turoglu HT. Abdel-Dayem HM, et al. Curr Opin Radiol. 1990 Dec;2(6):834-43. Curr Opin Radiol. 1990. PMID: 2149277 Review. No abstract available.
The utility of 99mTc-mercaptoacetyltriglycine in captopril renography.
Taylor A Jr, Martin LG. Taylor A Jr, et al. Am J Hypertens. 1991 Dec;4(12 Pt 2):731S-736S. doi: 10.1093/ajh/4.12.731s. Am J Hypertens. 1991. PMID: 1837994 Review.

See all similar articles

Cited by

Early side effects and first results of radioligand therapy with (177)Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study.
Ahmadzadehfar H, Rahbar K, Kürpig S, Bögemann M, Claesener M, Eppard E, Gärtner F, Rogenhofer S, Schäfers M, Essler M. Ahmadzadehfar H, et al. EJNMMI Res. 2015 Dec;5(1):114. doi: 10.1186/s13550-015-0114-2. Epub 2015 Jun 20. EJNMMI Res. 2015. PMID: 26099227 Free PMC article.
A new principle to normalize plasma concentrations allowing single-sample clearance determinations in both children and adults.
Bubeck B, Piepenburg R, Grethe U, Ehrig B, Hahn K. Bubeck B, et al. Eur J Nucl Med. 1992;19(7):511-6. doi: 10.1007/BF00185857. Eur J Nucl Med. 1992. PMID: 1386574
Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer.
Ahmadzadehfar H, Eppard E, Kürpig S, Fimmers R, Yordanova A, Schlenkhoff CD, Gärtner F, Rogenhofer S, Essler M. Ahmadzadehfar H, et al. Oncotarget. 2016 Mar 15;7(11):12477-88. doi: 10.18632/oncotarget.7245. Oncotarget. 2016. PMID: 26871285 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- S. Karger AG, Basel, Switzerland
Medical
- MedlinePlus Health Information